Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombosis prevention in adults with lower-leg cast immobilization after foot or ankle fracture
NL-OMON22436Recruiting
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- Apr 2009
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of nadroparin and fondaparinux in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) (3 arms), sponsored by Rode Kruis Ziekenhuis. Primary endpoint: Venous thromboembolism. Started Apr 2009; status: recruiting.
02
Drugs
nadroparinfondaparinux
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NL-OMON22436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22436.